Overview
Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC
Video-based interview
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how to assess opportunities to increase referral of minority patients to clinical trials and how to optimize overall care coordination among minority patients with NSCLC.
This activity is intended for oncologists, pulmonologists, specialty APPs, and primary care physicians.
This educational activity aims to not only bridge the sizeable knowledge gaps in management of NSCLC, but also move clinicians to recognize how their attitudes, behaviors and clinical practices fuel disparities in care, and create meaningful strategies that facilitate personalized, responsive care across their African American, Hispanic and other underserved patient populations. Such strategies include but are not limited to increased enrollment of minority patients in clinical trials, individualized treatment decisions considerate of patient-specific factors, and patient navigation program to mitigate socioeconomic constraints.
Upon completion of this activity, participants will be able to:
• Outline the latest research relating to NSCLC disparities of care
• Introduce strategies to improve precision medicine for underserved NSCLC patients
• Assess opportunities to increase referral of minority patients to clinical trials
• Apply tactics to improve care coordination, access to care and SDM for African American and Hispanic NSCLC patients
Topic Highlights:
• Overview of Disparities in NSCLC Care
• Review of Socioeconomic and Access to Care Drivers of Inequities
• How Evolving Treatment Landscape May Address Unmet Clinical Needs for Minority NSCLC Patients
• Interventions to Address Unmet Clinical Needs for Minority Patients
Sponsored by Rush University Medical Center and the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Genentech, a member of the Roche group.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Narjust Duma, MD
Assistant Professor of Medicine
Harvard Medical School
Associate Director of The Cancer Care Equity Program
Thoracic Oncologist – Lowe Center For Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MASally Lemke DNP, WHNP-BC
Director, Community Based Practices, Office of Community Health Equity and Engagement
Administrative Director, Affirm: The Rush Center for Gender, Sexuality, and Reproductive Health
Instructor, Department of Women, Children, and Family Health Nursing
Rush University Medical Center
Chicago, IL
Assistant Professor of Medicine
Harvard Medical School
Associate Director of The Cancer Care Equity Program
Thoracic Oncologist – Lowe Center For Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MASally Lemke DNP, WHNP-BC
Director, Community Based Practices, Office of Community Health Equity and Engagement
Administrative Director, Affirm: The Rush Center for Gender, Sexuality, and Reproductive Health
Instructor, Department of Women, Children, and Family Health Nursing
Rush University Medical Center
Chicago, IL
As a provider of continuing education, Rush University Medical Center asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity. All information disclosed must be shared by the participants/learners prior to the start of the educational activity.
Disclosure Statement (potential conflict to disclose):
Narjust Duma, MD discloses that she is a consultant to Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Mirati Therapeutics, Inc., NeoGenomics, and Pfizer.
Sally Lemke, DNP, WHNP-BC discloses that she has no relevant financial relationship(s) with ineligible companies to disclose.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL and Rush University Medical Center staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationship(s) with ineligible companies to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is being presented without bias and with commercial support.Rush University Medical Center designates this internet enduring material for a maximum of (0.75) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
